期刊文献+

酮替芬抗炎症作用对糖尿病大鼠的影响

下载PDF
导出
摘要 目的 探讨酮替芬(KT)抗炎症作用对糖尿病(DM)大鼠的影响及其机制.方法 以高糖高脂饲料对SD大鼠饮食诱导6周,随后一次性给予链脲佐菌素(STZ)制备DM大鼠模型,模型建立后KT实验组给予KT0.09mg/(kg·d)治疗8周,治疗前后分批处死实验大鼠,检测空腹血糖(FBG)、空腹胰岛素(FINS)水平,计算胰岛素敏感指数(ISI)、胰岛素抵抗指数(HOMA-IR),检测甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、炎症因子IL-6和TNF-α.结果 KT可降低FBG、FINS水平(P<0.05),降低TG、LDL-C水平(P<0.05),降低IL-6、TNF-α水平(P<0.05).结论 KT可能通过抑制肥大细胞脱颗粒、抑制NF-κ B激活,改善DM炎症及脂代谢紊乱状态,实现对胰岛细胞的保护作用. Objective To investigate the effect and mechanism of the anti-inflammatory role of Ketotifen in diabetic rats induced by high- caloriediet and streptozocin. Methods Male SD rats were fed with high-carbon hydrate-fat diet 6 weeks and ip given STZ to in-duce a type 2 diab-etes model. Rats of Ketotifen group were fed with Ketotifen 0.09mg/(kgod), and killed in batches in different time ( o, 8th week ) to test the fasting blood glucose ( FBG ) , and insulin ( FINS ) levels were measured, insulin sensitivity index ( ISI ) and homeostasis model assessment insulin resistance index ( HOMA-IR ) were calculated according to the value of FBG and FINS, to test the level of triglyceride ( TG ) , low density lipoprotein cholesterin ( LDL-C ) , Interleukin-6 ( IL-6 ) and tumor nectosis factor-alpha ( TNF- α) . Results Ketotifen suppressed serum glucose in diabetic rats (P〈0.05) , increase-d ISI and reduced HOMA-IR (P〈0.01) , lowered TG and LDL-C in diabetic rats (P〈0.05) , Ket-otifen reduced the level of IL-6, TNF-α. Conclusion Ketotifen can improve the flammatory and dyslipidaemia state of type 2 diabetic rats by inhibition of mast cell degranulation and NF- κB activation.
出处 《浙江临床医学》 2015年第10期1676-1677,共2页 Zhejiang Clinical Medical Journal
关键词 酮替芬 糖尿病 胰岛细胞 炎症 Ketotifen Diabetes mellitus Pancreatic cell Inflammatory
  • 相关文献

参考文献10

  • 1Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.Cell, 2006,124 (4): 823-835.
  • 2Siepe M,Goebel U,Mecklenburg A,et al.Pulsatile pulmonary perfusion during cardio-pulmonary bypass reduces the pulmonary inflammatory response.Ann Thorac Surg,2008,86(1): 115-122.
  • 3Liu J,Divoux A,Sun J,et al.Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.Nat Med,2009,15 (8) :940-945.
  • 4Theoharides TC,Alysandratos KD,Angelidou A, et al.Mast cells and inflammation.Biochim Biophys Acta,2012,18(22):21-33.
  • 5Caughey GH .Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev,2007,217(1):141-154.
  • 6Zhang B,Alysandratos KD,Angelidou A,et al.Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis.J Allergy Clin Immunol,2011,127(6):1522-1531.
  • 7Theoharides TC,Alysandratos KD,Angelidou A,et al.Mast cells and inflammation.Biochim Biophys Acta,2012,18(22):21-33.
  • 8Deng Y,Scherer PE. Adipokines as novel biomarkers and regulators of the metabolic syndrome.Ann N Y Acad Sci,2010,1212:1-19.
  • 9Majeed SK. Mast cell ditribution in rats.Arz neimittelf or schung, 1994, 44(3):370-374.
  • 10Zhang S,Liu J,Dragunow M,et al.Fibrillogenic amylin evokes islet beta-ceU apoptosis through linked activation of a caspase cascade and JNK1.J Biol Chem,2011,278(52):528-109.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部